| Year |
Citation |
Score |
| 2020 |
Constanti M, Boffa R, Floyd CN, Wierzbicki AS, McManus RJ, Glover M. Options for the diagnosis of high blood pressure in primary care: a systematic review and economic model. Journal of Human Hypertension. PMID 32461579 DOI: 10.1038/S41371-020-0357-X |
0.315 |
|
| 2019 |
Channavajjhala SK, Bramley R, Peltz T, Oosthuyzen W, Jia W, Kinnear S, Sampson B, Martin N, Hall IP, Bailey MA, Dear JW, Glover M. Urinary Extracellular Vesicle Protein Profiling and Endogenous Lithium Clearance Support Excessive Renal Sodium Wasting and Water Reabsorption in Thiazide-Induced Hyponatremia. Kidney International Reports. 4: 139-147. PMID 30596177 DOI: 10.1016/J.Ekir.2018.09.011 |
0.354 |
|
| 2018 |
Nadal J, Channavajjhala SK, Jia W, Clayton J, Hall IP, Glover M. Clinical and Molecular Features of Thiazide-Induced Hyponatremia. Current Hypertension Reports. 20: 31. PMID 29637415 DOI: 10.1007/S11906-018-0826-6 |
0.364 |
|
| 2017 |
Ware JS, Wain LV, Channavajjhala SK, Jackson VE, Edwards E, Lu R, Siew K, Jia W, Shrine N, Kinnear S, Jalland M, Henry AP, Clayton J, O'Shaughnessy KM, Tobin MD, ... ... Glover M, et al. Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia. The Journal of Clinical Investigation. 127: 3367-3374. PMID 28783044 DOI: 10.1172/JCI89812 |
0.667 |
|
| 2016 |
Channavajjhala S, Jia W, Jalland M, OʼShaughnessy K, Hall I, Glover M. OS 08-05 NOVEL MOLECULAR INSIGHTS IN URINARY EXOSOME PROTEIN PROFILING IN THIAZIDE INDUCED HYPONATREMIA. Journal of Hypertension. 34: e69. PMID 27643350 DOI: 10.1097/01.Hjh.0000500030.16778.Dd |
0.366 |
|
| 2015 |
Barber J, McKeever TM, McDowell SE, Clayton JA, Ferner RE, Gordon RD, Stowasser M, O'Shaughnessy KM, Hall IP, Glover M. A systematic review and meta-analysis of thiazide-induced hyponatraemia: time to reconsider electrolyte monitoring regimens after thiazide initiation? British Journal of Clinical Pharmacology. 79: 566-77. PMID 25139696 DOI: 10.1111/Bcp.12499 |
0.551 |
|
| 2014 |
Glover M, Ware JS, Henry A, Wolley M, Walsh R, Wain LV, Xu S, Van't Hoff WG, Tobin MD, Hall IP, Cook S, Gordon RD, Stowasser M, O'Shaughnessy KM. Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome). Clinical Science (London, England : 1979). 126: 721-6. PMID 24266877 DOI: 10.1042/Cs20130326 |
0.635 |
|
| 2013 |
Glover M, O'Shaughnessy KM. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia. Clinical and Experimental Pharmacology & Physiology. 40: 876-84. PMID 23683032 DOI: 10.1111/1440-1681.12115 |
0.665 |
|
| 2012 |
Glover M, Clayton J. Thiazide-induced hyponatraemia: epidemiology and clues to pathogenesis. Cardiovascular Therapeutics. 30: e219-26. PMID 21884020 DOI: 10.1111/J.1755-5922.2011.00286.X |
0.41 |
|
| 2012 |
Gordon R, Stowasser M, Xu S, Wolley M, Glover M, O'Shaughnessy K. Relevance of plasma aldosterone responsiveness to upright posture, hybrid steroids and histology of Aldosterone-Producing Adenomas (APAs) to the finding of KCNJ5 mutations in some APAs American Journal of Hypertension. 25: 1315-1315. DOI: 10.1038/Ajh.2012.134 |
0.543 |
|
| 2011 |
Glover M, Zuber AM, O'Shaughnessy KM. Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT. Cardiovascular Therapeutics. 29: 68-76. PMID 21167012 DOI: 10.1111/J.1755-5922.2010.00180.X |
0.66 |
|
| 2011 |
Glover M, O'shaughnessy KM. SPAK and WNK kinases: a new target for blood pressure treatment? Current Opinion in Nephrology and Hypertension. 20: 16-22. PMID 21088576 DOI: 10.1097/Mnh.0B013E32834132Bc |
0.666 |
|
| 2010 |
Glover M, Sweeny C, Davis B, O'Shaughnessy KM. A Single Amino Acid Substitution Makes WNK4 Susceptible to SB 203580 and SB 202190. The Open Medicinal Chemistry Journal. 4: 57-61. PMID 21249167 DOI: 10.2174/1874104501004010057 |
0.632 |
|
| 2010 |
Glover M, Mercier Zuber A, Figg N, O'Shaughnessy KM. The activity of the thiazide-sensitive Na(+)-Cl(-) cotransporter is regulated by protein phosphatase PP4. Canadian Journal of Physiology and Pharmacology. 88: 986-95. PMID 20962898 DOI: 10.1139/y10-080 |
0.613 |
|
| 2010 |
Rafiqi FH, Zuber AM, Glover M, Richardson C, Fleming S, Jovanović S, Jovanović A, O'Shaughnessy KM, Alessi DR. Role of the WNK-activated SPAK kinase in regulating blood pressure. Embo Molecular Medicine. 2: 63-75. PMID 20091762 DOI: 10.1002/Emmm.200900058 |
0.645 |
|
| 2009 |
Glover M, Zuber AM, O'Shaughnessy KM. Renal and brain isoforms of WNK3 have opposite effects on NCCT expression. Journal of the American Society of Nephrology : Jasn. 20: 1314-22. PMID 19470686 DOI: 10.1681/Asn.2008050542 |
0.634 |
|
| Show low-probability matches. |